Wockhardt's woes continue with another US FDA import alert
The US Food and Drug Administration (FDA) has hit Wockhardt with a second import alert this year, this time at its Chikalthana, India facility.
The US Food and Drug Administration (FDA) has hit Wockhardt with a second import alert this year, this time at its Chikalthana, India facility.
Actavis says it is restructuring a Californian manufacturing facility at a cost of 56 jobs weeks after the announced closure of a plant in North Carolina.